Literature DB >> 7492966

Cu/Zn-superoxide dismutase and glutathione peroxidase during aging.

J B de Haan1, F Cristiano, R C Iannello, I Kola.   

Abstract

During oxidative metabolism harmful reactive oxygen species (ROS) are generated. These species are neutralized by antioxidant enzymes. Firstly, superoxide dismutase (Sod) converts superoxide radicals (.O2-) to hydrogen peroxide (H2O2). Thereafter catalase (Cat) and glutathione peroxidase (Gpx) independently convert this to water. An imbalance in the ratio of Sod to Gpx and Cat results in the accumulation of H2O2 which may participate in the Fenton reaction, resulting in the formation of noxious hydroxyl radicals. These ROS are highly reactive and cause damage to macromolecules such as DNA, protein and lipids. We propose that it is the balance in the activity of the Sod to Gpx plus Cat ratio (Sod/(Gpx plus Cat)) that is an important determinant of cellular aging. This is based on our observation that an altered Cu/Zn-superoxide dismutase (Sod1)/(Gpx1 plus Cat) ratio exists in the brain of aging mice and that this correlates with increased lipid damage. Conversely, aging liver and kidney have an unaffected Sod1/(Gpx1 plus Cat) ratio and lipid damage is not increased with aging. We also examine the Sod1 to Gpx1 ratio in Down syndrome tissue and show that all organs have an altered ratio. This may contribute to the premature aging seen in these individuals. We show that binding of a p50/p65 complex to an NF-kappa B consensus sequence is enhanced by H2O2 treatment in NIH3T3 cells. Thus an altered Sod1/(Gpx1 plus Cat) ratio may also affect gene expression by altering the binding and/or availability of transcription factors to DNA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7492966

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  22 in total

1.  Peroxide modulation of slow onset potentiation in rat hippocampus.

Authors:  J M Auerbach; M Segal
Journal:  J Neurosci       Date:  1997-11-15       Impact factor: 6.167

2.  Ocular pharmacokinetic study on baicalin in lens of rabbits following intragastric administration.

Authors:  Jia Zhiyan; Bai Zhengzhong; Jiang Liange; Zhang Shujie; Duo Kai; Cui Hao; Yu Yongbin; Liu Ping
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-10-10       Impact factor: 3.117

3.  Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease.

Authors:  Fabio Di Domenico; Gilda Pupo; Antonella Tramutola; Alessandra Giorgi; Maria Eugenia Schininà; Raffaella Coccia; Elizabeth Head; D Allan Butterfield; Marzia Perluigi
Journal:  Free Radic Biol Med       Date:  2014-03-25       Impact factor: 7.376

Review 4.  Disturbance of redox homeostasis in Down Syndrome: Role of iron dysmetabolism.

Authors:  Eugenio Barone; Andrea Arena; Elizabeth Head; D Allan Butterfield; Marzia Perluigi
Journal:  Free Radic Biol Med       Date:  2017-07-10       Impact factor: 7.376

5.  Induction of antioxidant enzyme activity by hyperoxia (60 % O2) in the developing chick embryo.

Authors:  J C van Golde; P J Borm; M C Wolfs; E H Rhijnsburger; C E Blanco
Journal:  J Physiol       Date:  1998-05-15       Impact factor: 5.182

Review 6.  HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology.

Authors:  Eugenio Barone; Elizabeth Head; D Allan Butterfield; Marzia Perluigi
Journal:  Free Radic Biol Med       Date:  2016-11-10       Impact factor: 7.376

7.  High GPX1 expression promotes esophageal squamous cell carcinoma invasion, migration, proliferation and cisplatin-resistance but can be reduced by vitamin D.

Authors:  Xiangfeng Gan; Baishen Chen; Zhuojian Shen; Yeqing Liu; Haifeng Li; Xuan Xie; Xia Xu; Haigang Li; Zhiquan Huang; Ju Chen
Journal:  Int J Clin Exp Med       Date:  2014-09-15

8.  Postnatal expression of glucose-6-phosphate dehydrogenase in different brain areas.

Authors:  P Ninfali; G Aluigi; A Pompella
Journal:  Neurochem Res       Date:  1998-09       Impact factor: 3.996

Review 9.  Polyubiquitinylation Profile in Down Syndrome Brain Before and After the Development of Alzheimer Neuropathology.

Authors:  Antonella Tramutola; Fabio Di Domenico; Eugenio Barone; Andrea Arena; Alessandra Giorgi; Laura di Francesco; Maria Eugenia Schininà; Raffaella Coccia; Elizabeth Head; D Allan Butterfield; Marzia Perluigi
Journal:  Antioxid Redox Signal       Date:  2016-10-26       Impact factor: 8.401

10.  Overexpression of FABP7 in Down syndrome fetal brains is associated with PKNOX1 gene-dosage imbalance.

Authors:  Ma Francisca Sánchez-Font; Anna Bosch-Comas; Roser Gonzàlez-Duarte; Gemma Marfany
Journal:  Nucleic Acids Res       Date:  2003-06-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.